Yang et al demonstrated that UCA1 regulates cell cycle progression through CREB via PI3K-AKT-dependent signaling pathways and may serve as a new diagnostic and therapeutic target in bladder cancer (8). This evidence concerns the gene AKT1 and urinary bladder carcinoma.